Rasuritek

Rasuritek Uses, Dosage, Side Effects, Food Interaction and all others data.

Rasuritek is a recombinant urate-oxidase enzyme produced by a genetically modified Saccharomyces cerevisiae strain. The cDNA coding for rasburicase was cloned from a strain of Aspergillus flavus.

Drugs used to treat lympohoid leukemia, non-Hodgkin's lymphoma and acute myelogenous leukemia often lead to the accumulation of toxic plasma levels of purine metabolites (i.e. uric acid). The injection of rasburicase reduces levels of uric acid and mitigates the toxic effects of chemotherapy induced tumor lysis.

Table Of contents

• Rasuritek
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Rasuritek
Availability	Prescription only
Generic	Rasburicase
Rasburicase Other Names	Rasburicasa, Rasburicase, Urate oxidase
Related Drugs	allopurinol, sodium bicarbonate, Zyloprim, Elitek, Aloprim
Type
Formula	C1521H2381N417O461S7
Weight	34109.5 Da
Groups	Approved, Investigational
Therapeutic Class
Manufacturer
Available Country	Japan
Last Updated:	September 19, 2023 at 7:00 am

Uses

Rasuritek is a recombinant form of urate-oxidase enzyme used to treat hyperuricemia following chemotherapy for leukemias and non-Hodgkin's lymphoma.

For treatment of hyperuricemia, reduces elevated plasma uric acid levels (from chemotherapy)

Rasuritek is also used to associated treatment for these conditions: Hyperuricemia

How Rasuritek works

Rasuritek catalyzes enzymatic oxidation of uric acid into an inactive and soluble metabolite (allantoin).

Food Interaction

No interactions found.

Rasuritek Drug Interaction

Unknown: aripiprazole, papain/urea topical, charcoal, doxorubicin, oxymetazoline nasal, antihemophilic factor/von willebrand factor, darbepoetin alfa, azithromycin, sulfamethoxazole / trimethoprim, meperidine, fluorouracil topical, heparin, levocarnitine, phenazopyridine, vitamin a topical, bioflavonoids, sotalol, cyanocobalamin, cholecalciferol, ondansetron

Rasuritek Disease Interaction

Major: G6PD deficiency

Volume of Distribution

• 110 to 127 mL/kg [pediatric patients]
• 75.8 to 138 mL/kg [adult patients]

Half Life

18 hours

Innovators Monograph

You find simplified version here Rasuritek